Invention for Anti-PD-1 antibodies, and their use.

Invented by Yasmina Noubia Abdiche, Helen Kim Cho, Wei-Hsien Ho, Karin Ute JOOSS, Arvind Rajpal, Sawsan Youssef, Rinat Neuroscience Corp The Market for Anti-PD-1 Antibodies and Their Use In recent years, the field of cancer immunotherapy has witnessed significant advancements, revolutionizing the way we treat various types of cancer. Among the most promising developments is …

Invention for Methods of selecting treatment regimens in cancer patients and predicting their outcomes

Invented by Nadia Harbeck, Ronald E. Kates, Manfred Schmitt, FOEKENS John A, Biomedica Diagnostics Inc The market for methods of selecting treatment regimens in cancer patients and predicting their outcomes has seen significant growth in recent years. As cancer continues to be a leading cause of death worldwide, the need for personalized and effective treatment …

Invention for Methods of treating autoimmune diseases using monoclonal immunosuppressive antibodies with reduced toxicities

Invented by Scott Koenig, Ronald L. Wilder, Ezio Bonvini, Leslie S. Johnson, Provention Bio Inc The market for methods of treating autoimmune diseases using monoclonal immunosuppressive antibodies with reduced toxicities is rapidly expanding as researchers and pharmaceutical companies strive to develop safer and more effective treatments for these debilitating conditions. Autoimmune diseases occur when the …

Invention for Monovalent Metal Cation Dry Powders for Inhalation

Invented by Jean C. Sung, Michael M. Lipp, Pulmatrix Operating Co Inc The market for monovalent metal cation dry powders for inhalation has been steadily growing in recent years, driven by the increasing prevalence of respiratory diseases and the demand for more effective and convenient treatment options. These dry powders offer several advantages over traditional …

Invention for Anti-CD33 antibody agents

Invented by Sayed Shahabuddin Hoseini, Nai-Kong V. Cheung, Memorial Sloan Kettering Cancer Center The market for Anti-CD33 antibody agents has been witnessing significant growth in recent years. CD33 is a cell surface antigen that is primarily expressed on the surface of myeloid cells, including leukemic blasts in acute myeloid leukemia (AML). Anti-CD33 antibody agents are …

Invention for Prevention and reduction of disulfide bonds during the recombinant polypeptide production

Invented by Yung-Hsiang Kao, Michael W. Laird, Melody Trexler Schmidt, Rita L. Wong, Daniel P. Hewitt, Genentech Inc The market for prevention and reduction of disulfide bonds during recombinant polypeptide production is witnessing significant growth due to the increasing demand for recombinant proteins in various industries such as pharmaceuticals, biotechnology, and food and beverages. Disulfide …

Invention for Compositions for activating the?stimulator interferon gene 13 dependent signalling

Invented by George Edwin Katibah, David Kanne, Leonard Sung, Kelsey Gauthier, Laura Hix Glickman, Justin Leong, Sarah M. McWhirter, Thomas W. Dubensky, Jr., Chinook Therapeutics Inc The market for compositions for activating the stimulator interferon gene 13 (STING) dependent signaling is rapidly growing as researchers and pharmaceutical companies recognize the potential of targeting this pathway …

Invention for Stable formulations and methods for use of anti-programmed death receptor 1 antibodies

Invented by Manoj K. Sharma, Wendy Benjamin, Sarita Mittal, Ashwin Basarkar, Chakravarthy Nachu Narasimhan, Ramesh S. Kashi, Mohammed Shameem, Soumendu Bhattacharya, Yogita Krishnamachari, Merck Sharp and Dohme LLC The Market for Stable Formulations and Methods for Use of Anti-Programmed Death Receptor 1 Antibodies Introduction: The development of immunotherapy has revolutionized the field of oncology by …

Invention for Erythrocyte-binding therapeutics

Invented by Jeffrey A. Hubbell, Stephan Kontos, Karen Y. Dane, Ecole Polytechnique Federale de Lausanne EPFL The market for erythrocyte-binding therapeutics is rapidly growing, as more and more pharmaceutical companies are investing in research and development of these innovative drugs. Erythrocyte-binding therapeutics are a type of medication that targets red blood cells, which are responsible …

Invention for Anti-activin A antibodies

Invented by Huiquan Han, Qing Chen, Keith Soo-Nyung Kwak, Xiaolan Zhou, Amgen Inc Anti-activin A antibodies are a type of protein that can be used to treat a variety of medical conditions. Activin A is a protein that is involved in a number of important biological processes, including cell growth and differentiation, inflammation, and wound …